A significant discovery in cancer study is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer protector protein is frequently inactivated in several types of malignancies, https://xyzbookmarks.com/story21754697/nanobodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-tumor-management